Health and Medicine News This Week: Breakthroughs You Should Know - The Vanderbilt Report

• A wave of high-profile resignations and firings has created a leadership vacuum at the top of the CDC and FDA. • These departures suggest the Trump administration may be pivoting away from specific goals of the "Make America Healthy Again" (MAHA) movement.

• The World Health Organization (WHO) has declared the Ebola outbreak a public health emergency, prompting employers to review operational and workforce safety considerations. • While the risk to the general population in Europe remains very low, individuals returning from affected areas are advised to seek medical care if symptoms appear within 21 days.

• The British Palace has issued an official statement announcing that a member of the Royal Family will undergo major surgery. • The decision to proceed with the operation follows a period where the royal's health reportedly worsened.

• MarketBeat’s stock screener tool identified Eli Lilly and Company, Pfizer, and AbbVie as the top three pharmaceutical stocks to watch on June 8th. • These companies operate within the pharmaceutical sector, focusing on the development, manufacturing, and sale of prescription drugs, vaccines, and over-the-counter medicines.

• A phase II trial published in Nature Medicine found that combining the drug apitegromab with tirzepatide (Zepbound) effectively preserves lean muscle mass, potentially mitigating the muscle loss known as "Ozempic butt." • Massachusetts General Hospital has established a novel vascular clinic specifically designed to provide critical care to homeless individuals to prevent amputations caused by peripheral artery disease.

• The COVID-19 pandemic in early 2020 exposed critical vulnerabilities in global health systems and their inability to manage large-scale infectious disease outbreaks. • The crisis highlighted several converging risk factors, including agricultural intensification, increased human-animal contact, rapid urbanization, and shifting climatic patterns.

• During the Seventy-ninth World Health Assembly (WHA79) in May 2026, global health leaders reaffirmed their commitment to the Immunization Agenda 2030 (IA2030) to ensure universal vaccine access. • On the sidelines of the assembly, the Tuberculosis Vaccine Accelerator Council held its fourth meeting to coordinate efforts among funders, technical agencies, and civil society.

• Scientists have identified a new blood marker capable of detecting lung cancer years earlier than traditional imaging scans. • Researchers from the University of Cambridge and DIOSynVax successfully completed the first human clinical trial for a "universal" coronavirus vaccine.

• Children’s Tumor Foundation (CTF) CEO Annette Bakker reports that over 5,000 potential treatments for rare diseases are currently shelved by pharmaceutical companies. • The organization is working to rescue these dormant drug candidates to provide options for patients with rare conditions who lack viable therapies.

• The Pharmaceutical Journal has released a detailed analysis of the new community pharmacy contract. • The report examines whether the new framework will stabilize medicines funding and evaluates its promises regarding long-term systemic reform.

• A new outbreak of the Ebola Bundibugyo virus has emerged, affecting the Democratic Republic of Congo, Uganda, and surrounding neighboring countries. • Pharmaceutical and biotech companies are collaborating with global health and humanitarian partners to coordinate a rapid medical response.